Cargando…

Sympathetic stimulation with norepinephrine may come at a cost

Detalles Bibliográficos
Autores principales:	Herat, Lakshini Y., Schlaich, Markus P., Matthews, Vance B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404498/ https://www.ncbi.nlm.nih.gov/pubmed/30762006 http://dx.doi.org/10.4103/1673-5374.250576

Ejemplares similares

The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney
por: Matthews, Jennifer, et al.
Publicado: (2023)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Herat, Lakshini Y., et al.
Publicado: (2018)

The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status
por: Matthews, Jennifer, et al.
Publicado: (2023)

Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
por: Matthews, Jennifer, et al.
Publicado: (2021)

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
por: Herat, Lakshini Y., et al.
Publicado: (2022)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
por: Magno, Aaron L., et al.
Publicado: (2019)

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice
por: Herat, Lakshini, et al.
Publicado: (2017)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

SGLT2 Inhibitor-Induced Sympathoexcitation in White Adipose Tissue: A Novel Mechanism for Beiging
por: Matthews, Jennifer R., et al.
Publicado: (2020)

The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy
por: Matthews, Jennifer Rose, et al.
Publicado: (2022)

A cautionary note for researchers treating mice with the neurotransmitter norepinephrine
por: Matthews, Vance B., et al.
Publicado: (2018)

The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α
por: Magno, Aaron L., et al.
Publicado: (2020)

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes
por: Herat, Lakshini Yasaswi, et al.
Publicado: (2023)

TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes
por: Agostino, Mark, et al.
Publicado: (2021)

Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice
por: Herat, Lakshini Y, et al.
Publicado: (2020)

Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2021)

The Schlager mouse as a model of altered retinal phenotype
por: Herat, Lakshini Y., et al.
Publicado: (2019)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Carnagarin, Revathy, et al.
Publicado: (2019)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension
por: Frost, Shaun, et al.
Publicado: (2021)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)

Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
por: Fage, Nicolas, et al.
Publicado: (2023)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
por: Thorp, Alicia A., et al.
Publicado: (2015)

Advances in Sympathetic Nerve Recording in Humans
por: Lambert, Elisabeth, et al.
Publicado: (2012)

An updated “norepinephrine equivalent” score in intensive care as a marker of shock severity
por: Kotani, Yuki, et al.
Publicado: (2023)

Neocentromeres Come of Age
por: Marshall, Owen J., et al.
Publicado: (2009)

Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models
por: Wu, Hsueh-Fu, et al.
Publicado: (2022)

The Silkworm Coming of Age—Early
por: Feyereisen, René, et al.
Publicado: (2012)

The Coming Primary Care Revolution
por: Ellner, Andrew L., et al.
Publicado: (2017)

Coming of Age for the Photoreceptor Synapse
por: Townes-Anderson, Ellen, et al.
Publicado: (2021)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Has the time come for preprints in biology?
por: Bhalla, Needhi
Publicado: (2016)

The Future Comes Early for Medical Educators
por: Minter, Daniel J., et al.
Publicado: (2020)

Coming together to define membrane contact sites
por: Scorrano, Luca, et al.
Publicado: (2019)

Freedom of assembly: metabolic enzymes come together
por: Simonet, Jacqueline C., et al.
Publicado: (2020)

Bridging the communication gap: cardiomyocytes reciprocate sympathetic nerve signalling
por: Salamon, Rebecca J., et al.
Publicado: (2022)

Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development
por: Fermini, Bernard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_srl6jo32a784qh8miov2200i8c